CD40LG and Zika virus infectious disease: We seek to test the less cross-reactive ZIKV IgM antibodies as a tool to distinguish acute ZIKV infections from other flavivirus and extend the diagnostic window provided by reverse transcriptase–polymerase chain reaction (RT-PCR).